We are live on ! Find out more
MAG

Millrace Asset Group Portfolio holdings

AUM $98.4M
1-Year Est. Return 63.71%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+63.71%
3 Year Est. Return
+112.82%
5 Year Est. Return
+625.06%
10 Year Est. Return
+4,658.38%
AUM
$103M
AUM Growth
-$950K
Cap. Flow
-$9.3M
Cap. Flow %
-9.01%
Top 10 Hldgs %
26.75%
Holding
83
New
22
Increased
13
Reduced
27
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 40.43%
2 Healthcare 22.23%
3 Industrials 14.66%
4 Consumer Discretionary 8.29%
5 Financials 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
76
DELISTED
Enzo Biochem, Inc.
ENZ
-170,144
Closed -$1.39M
CAMP
77
DELISTED
CalAmp Corp.
CAMP
-1,422
Closed -$700K
CAI
78
DELISTED
CAI International, Inc.
CAI
-37,191
Closed -$1.05M
ELGX
79
DELISTED
Endologix Inc
ELGX
-12,500
Closed -$669K
APTI
80
DELISTED
Apptio, Inc. Class A Common Stock
APTI
-91,000
Closed -$2.14M
OCLR
81
DELISTED
Oclaro Inc.
OCLR
-87,287
Closed -$588K
EMKR
82
DELISTED
Emcore Corp
EMKR
-12,485
Closed -$805K
VG
83
DELISTED
Vonage Holdings Corporation
VG
-220,758
Closed -$2.25M

Similar funds

Millrace Asset Group's Q1 2018 Portfolio in Review

As of Q1 2018, Millrace Asset Group held 83 positions worth $103M, down 0.91% from $104M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Millrace Asset Group withdrew a net $9.3M in Q1 2018, closing 19 positions and reducing 27 holdings. Its most notable exit was Coherent, an estimated $2.68M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 46% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Millrace Asset Group opened a new position in Genomic Health, Inc. worth $2.03M.

  • Millrace Asset Group's largest Q1 2018 buy was Genomic Health, Inc.: 65,000 shares worth $2.03M.
  • Millrace Asset Group added most to Cantaloupe in Q1 2018, an estimated $1.09M increase.
  • Millrace Asset Group's biggest Q1 2018 reduction was BioTelemetry, Inc., cutting an estimated $2.01M.
  • Millrace Asset Group fully exited Coherent in Q1 2018, selling an estimated $2.68M.
  • Millrace Asset Group's ten largest holdings make up 27% of its $103M portfolio in Q1 2018.
  • Millrace Asset Group opened 22 new positions and closed 19 in Q1 2018.
  • Millrace Asset Group's portfolio value fell 0.91% quarter-over-quarter to $103M.

Based on Millrace Asset Group's 13F filing for Q1 2018, filed 15 May 2018.